Related Experiment Video
Updated: May 18, 2026

Modified Radical Neck Dissection for Cervical Metastasis
Published on: February 20, 2026
Persistent neck disease after chemoradiation for head and neck squamous cell carcinoma
J G Sanders1, K G Smith, M B Jameson
1Department of Otolaryngology-Head and Neck Surgery, Wellington Hospital, Hamilton, New Zealand. jgsanders@doctors.org.uk
Objective:
This study aimed to identify the incidence of residual viable neck disease in patients with mucosal squamous cell carcinoma of the upper aero-digestive tract, following primary chemoradiation at a tertiary centre.
Study Design:
Retrospective review.
Methods:
Retrospective chart review of patients treated with primary chemoradiation for squamous cell carcinoma of the aero-digestive tract between August 2001 and August 2008. Neck status pre- and post-treatment was the primary focus.
Results:
Forty-two patients with node-positive disease prior to chemoradiation were included. Thirty-seven (88.1 per cent) achieved complete response to treatment: no patient in this group underwent neck dissection, five died due to recurrence at the primary site or distant metastasis, and none suffered neck recurrence. Five (11.9 per cent) patients achieved partial response to chemoradiation and underwent neck dissection; viable tumour was found in one patient.
Conclusion:
Our data support conservative management of the neck in patients with complete response to chemoradiation, and consolidation neck dissection in patients with partial response.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

